Haaber, Rikke S
20  results:
Search for persons X
?
4

Chimeric Antigen Receptor T Cells Targeting CD79b Show Effi..:

Ormhøj, Maria ; Scarfò, Irene ; Cabral, Maria L...
Ormhøj , M , Scarfò , I , Cabral , M L , Bailey , S R , Lorrey , S J , Bouffard , A A , Castano , A P , Larson , R C , Riley , L S , Schmidts , A , Choi , B D , Andersen , R S , Cédile , O , Nyvold , C G , Haaber , J , Gjerstorff , M F , Ditzel , H J , Weinstock , D M , Barington , T , Frigault , M J & Maus , M V 2019 , ' Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19 ' , Clinical Cancer Research , vol. 25 , no. 23 , pp. 7046-7057 . https://doi.org/10.1158/1078-0432.CCR-19-1337.  , 2019
 
?
8

Staphylococcus aureuscoagulases are exploitable yet stable ..:

Trivedi, Urvish ; Madsen, Jonas S. ; Everett, Jake...
Proceedings of the National Academy of Sciences.  115 (2018)  50 - p. , 2018
 
?
9

Staphylococcus aureus coagulases are exploitable yet stable..:

Trivedi, Urvish ; Madsen, Jonas S. ; Everett, Jake...
Proceedings of the National Academy of Sciences of the United States of America.  115 (2018)  50 - p. E11771-E11779 , 2018
 
?
 
?
14

POSTER: IBCL-474 Epcoritamab + R2 Regimen and Responses in ..:

Merryman, Reid W. ; Belada, David ; Sureda, Anna...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S210 , 2023
 
?
 
1-15